Cardiovascular Research Foundation, New York Report issue

Foundation Phase 2 Phase 3

Organization Overview

First Clinical Trial
2005
NCT00433966
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now